NCT04365127View on ClinicalTrials.gov

Progesterone for the Treatment of COVID-19 in Hospitalized Men

PHASE1CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

April 27, 2020

Primary Completion Date

August 20, 2020

Study Completion Date

August 20, 2020

Conditions
COVID-19Sars-CoV2
Interventions
DRUG

Progesterone 100 MG

Subcutaneous administration twice daily

Trial Locations (1)

90035

Cedars Sinai Medical Center, Los Angeles

Sponsors
All Listed Sponsors
collaborator

IBSA Institut Biochimique SA

INDUSTRY

lead

Sara Ghandehari

OTHER

NCT04365127 - Progesterone for the Treatment of COVID-19 in Hospitalized Men | Biotech Hunter | Biotech Hunter